DK662687A - Anvendelse af tricycliske carbazoloner - Google Patents

Anvendelse af tricycliske carbazoloner

Info

Publication number
DK662687A
DK662687A DK662687A DK662687A DK662687A DK 662687 A DK662687 A DK 662687A DK 662687 A DK662687 A DK 662687A DK 662687 A DK662687 A DK 662687A DK 662687 A DK662687 A DK 662687A
Authority
DK
Denmark
Prior art keywords
carbazolones
tricyclic
tricyclic carbazolones
Prior art date
Application number
DK662687A
Other languages
Danish (da)
English (en)
Other versions
DK662687D0 (da
Inventor
Michael Brian Tyers
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868630075A external-priority patent/GB8630075D0/en
Priority claimed from GB878726424A external-priority patent/GB8726424D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DK662687D0 publication Critical patent/DK662687D0/da
Publication of DK662687A publication Critical patent/DK662687A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK662687A 1986-12-17 1987-12-16 Anvendelse af tricycliske carbazoloner DK662687A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868630075A GB8630075D0 (en) 1986-12-17 1986-12-17 Medicaments
GB878726424A GB8726424D0 (en) 1987-11-11 1987-11-11 Medicaments

Publications (2)

Publication Number Publication Date
DK662687D0 DK662687D0 (da) 1987-12-16
DK662687A true DK662687A (da) 1988-06-18

Family

ID=26291706

Family Applications (1)

Application Number Title Priority Date Filing Date
DK662687A DK662687A (da) 1986-12-17 1987-12-16 Anvendelse af tricycliske carbazoloner

Country Status (15)

Country Link
US (1) US4845115A (ja)
EP (1) EP0275668B1 (ja)
JP (1) JP2608078B2 (ja)
KR (1) KR950013450B1 (ja)
AU (1) AU618520B2 (ja)
CY (1) CY1692A (ja)
DE (1) DE3782028T2 (ja)
DK (1) DK662687A (ja)
ES (1) ES2052585T3 (ja)
GR (1) GR3006255T3 (ja)
HK (1) HK36693A (ja)
IE (1) IE60991B1 (ja)
IL (1) IL84845A0 (ja)
NZ (1) NZ222950A (ja)
PH (1) PH25025A (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200414A (en) * 1986-12-17 1993-04-06 Glaxo Group Limited Methods for the treatment of cognitive disorders
US5190954A (en) * 1986-12-17 1993-03-02 Glaxo Group Limited Methods for the treatment of cognitive disorders
GB8805269D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments
US5229407A (en) * 1988-09-01 1993-07-20 Glaxo Group Limited Medicaments
GB8820651D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
GB8914804D0 (en) * 1989-06-28 1989-08-16 Glaxo Group Ltd Process
US5225407A (en) * 1990-02-22 1993-07-06 Glaxo Group Limited 5-HT3 receptor antagonists for the treatment of autism
EP0492020A1 (en) * 1990-12-21 1992-07-01 Merrell Dow Pharmaceuticals Inc. Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders
WO1993000075A1 (en) * 1991-06-26 1993-01-07 Sepracor, Inc. Methods and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron
JPH06508836A (ja) * 1991-06-26 1994-10-06 セプラコア，インコーポレーテッド 光学的に純粋なｒ（＋）オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物
AU683447B2 (en) * 1993-03-08 1997-11-13 Fujisawa Pharmaceutical Co., Ltd. Medicament for treating or preventing cerebrovascular diseases
ZA989365B (en) * 1997-10-15 1999-04-15 Boehringer Mannheim Pharm Corp Preparation for treating alzheimer's disease
ATE285235T1 (de) * 1999-01-07 2005-01-15 Gerolymatos P N Sa Verwendung von phanquinon zur behandlung und vorbeugung von gedächtnisschwund
WO2000051582A2 (en) 1999-03-01 2000-09-08 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
US20020115707A1 (en) * 2001-01-11 2002-08-22 Rami Lidor-Hadas Process for preparing pure ondansetron hydrochloride dihydrate
GB0701970D0 (en) 2007-02-01 2007-03-14 Wilson Stuart Treatment of protein aggregation diseases
US20100298397A1 (en) * 2009-05-19 2010-11-25 Singh Nikhilesh N Method of treatment of obsessive compulsive disorder with ondansetron

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531083B1 (fr) * 1982-06-29 1986-11-28 Sandoz Sa Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
FR2557110B1 (fr) * 1983-12-23 1989-11-24 Sandoz Sa Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments
NZ210940A (en) * 1984-01-25 1989-08-29 Glaxo Group Ltd 1,2,3-trihydro-3-(1h-imidazol-1-ylmethyl)-4h-carbazol-4-one derivatives and pharmaceutical compositions
DE3680123D1 (en) * 1985-01-23 1991-08-14 Glaxo Group Ltd Tetrahydrocarbazolonderivate.
US4605652A (en) * 1985-02-04 1986-08-12 A. H. Robins Company, Inc. Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
DE385517T1 (de) * 1985-03-14 1991-07-25 Beecham Group P.L.C., Brentford, Middlesex, Gb Arzneimittel zur behandlung von erbrechen.
US4624961A (en) * 1985-04-17 1986-11-25 A. H. Robins Company, Incorporated Method for enhancing memory or correcting memory deficiency with arylamidopyrazolidines and arylamidodiazabicycloalkanes
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
NL8701682A (nl) * 1986-07-30 1988-02-16 Sandoz Ag Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten.

Also Published As

Publication number Publication date
AU8261487A (en) 1988-06-23
HK36693A (en) 1993-04-23
PH25025A (en) 1991-01-28
DE3782028T2 (de) 1993-02-18
KR950013450B1 (ko) 1995-11-08
AU618520B2 (en) 1992-01-02
ES2052585T3 (es) 1994-07-16
EP0275668A3 (en) 1989-10-11
JP2608078B2 (ja) 1997-05-07
US4845115A (en) 1989-07-04
EP0275668B1 (en) 1992-09-30
KR880007074A (ko) 1988-08-26
IE60991B1 (en) 1994-09-07
DK662687D0 (da) 1987-12-16
CY1692A (en) 1994-01-14
JPS63253083A (ja) 1988-10-20
NZ222950A (en) 1997-06-24
DE3782028D1 (de) 1992-11-05
IL84845A0 (en) 1988-06-30
EP0275668A2 (en) 1988-07-27
IE873414L (en) 1988-06-17
GR3006255T3 (ja) 1993-06-21

Similar Documents

Publication Publication Date Title
DK208188A (da) Anvendelse af 17-ketosteroider
DK363887A (da) Anvendelse af bromcruptin
DK662687A (da) Anvendelse af tricycliske carbazoloner
DK193588A (da) Anvendelser af dopaminagonister
DK399088D0 (da) Anvendelse af olefine forbindelser
DK185988D0 (da) Anvendelse af antigen
DK477287D0 (da) Tricycliske forbindelser
DK293086A (da) Anvendelse af substituerede azabicycloforbindelser
DK38593A (da) Alkoxymethylethere af glyceroler
DK120389A (da) Anvendelse af progestin
DK87888A (da) Terapeutisk anvendelse af tindijoddeuteroporfyrin
DK104389A (da) Anvendelse af imidazolderivater
DK564886D0 (da) Fungicid anvendelse af tetrahydrobenzothienylurinstofderivater
DK316589D0 (da) Substituerede azacyclohexylderivater af rifamyciner
DK541487D0 (da) Sammenfoejning af materialer
IS1456B6 (is) Þríhringja ketónar
KR880007430U (ko) 고리
DK98690D0 (da) Hidtil ukendte forbindelser af anthraquinonraekken
DK185987A (da) Anvendelse af prostaglandiner
DK153045C (da) Sammenkobling af fortrinsvis langstrakte elementer
DK333587D0 (da) Anvendelse af pyridinderivater
DK355787D0 (da) Tricycliske forbindelser
DK100885A (da) Anvendelse af pentacycliske forbindelser
DK171389D0 (da) Anvendelse af acetazolamid
DK0402857T3 (da) Anvendelse af 17beta-cyclopropylamino-androsten-derivater

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment